News
Andrew Wilks Wins the Prime Minister's Award
Cytopia founder Andrew Wilks and Chris Burns won the 2024 Prime Minister's Prize for Innovation for inventing momelotinib, a rare blood-cancer drug the US FDA approved in 2023.
Company
Cytopia
Melbourne, VIC
Funding history
Investors
Every investor coverage indicates participated in a round Cytopia raised.
What Cytopia bought
Companies Cytopia acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
People
Coverage
Stories naming Cytopia. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Funding announcement
Professor got nothing from the $2.8b sale of his molecule, and that's okay
Profile of scientist-entrepreneur Andrew Wilks covering the GSK sale of his cancer molecule, his SYNthesis BioVentures fund's family-office backers, and portfolio plays including Aculeus Therapeutics.
Fund close
$30m
Andrew Wilks in Weekend Australian
Profile of scientist-entrepreneur Andrew Wilks tracing his path from cancer research to founding drug developer Cytopia and launching SYNthesis BioVentures, a therapeutics fund that recently secured $30 million from wealthy individuals and family offices.